Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The University of Cape Town Lung Institute is a leading center for clinical research and healthcare services in Africa, specializing in respiratory diseases. Established in 1999, it operates as a wholly-owned subsidiary of the University of Cape Town and functions as a contract research organization (CRO) and a clinical service provider. The institute focuses on tuberculosis (TB), asthma, COPD, and allergy research, conducting high-impact clinical trials and providing specialized medical care. It plays a critical role in developing new diagnostic tools and treatments for lung health in resource-limited settings. The organization is globally recognized for its contributions to global health policy and its collaborations with international pharmaceutical companies and philanthropic foundations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on University of Cape Town Lung Institute.